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Abstract
Objective To investigate factors affecting the pattern of motor brain activation reported in people with Parkinson’s (PwP), aiming
to differentiate disease-specific features from treatment effects.
Methods A co-ordinate-based-meta-analysis (CBMA) of functional motor neuroimaging studies involving patients with
Parkinson’s (PwP), and healthy controls (HC) identified 126 suitable articles. The experiments were grouped based on subject
feature, medication status (onMed/offMed), deep brain stimulation (DBS) status (DBSon/DBSoff) and type of motor initiation.
Results HC and PwP shared similar neural networks during upper extremity motor tasks but with differences of reported frequency
in mainly bilateral putamen, insula and ipsilateral inferior parietal and precentral gyri. The activation height was significantly
reduced in the bilateral putamen, left SMA, left subthalamus nucleus, right thalamus and right midial global pallidum in
PwPoffMed (vs. HC), and pre-SMA hypoactivation correlated with disease severity. These changes were not found in patients on
dopamine replacement therapy (PwPonMed vs. HC) in line with a restorative function. By contrast, left SMA and primary motor
cortex showed hyperactivation in the medicated state (vs. HC) suggesting dopaminergic overcompensation. Deep-brain stimulation
(PwP during the high frequency subthalamus nucleus (STN) DBS vs. no stimulation) induced a decrease in left SMA activity and
the expected increase in the left subthalamic/thalamic region regardless of hand movement. We further demonstrated a disease
related effect of motor intention with only PwPoffMed showing increased activation in the medial frontal lobe in self-initiated studies.
Conclusion We describe a consistent disease-specific pattern of putaminal hypoactivation during motor tasks that appears
reversed by dopamine replacement. Inconsistent reports of altered SMA/pre-SMA activation can be explained by task- and
medication-specific variation in intention. Moreover, SMA activity was reduced during STN-DBS, while dopamine-induced
hyperactivation of SMAwhich might underpin hyperdynamic L-dopa related overcompensation.
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Introduction
Parkinson’s disease (PD) is the second most common neuro-
degenerative disorder (de Lau and Breteler 2006).
Dopaminergic deficiency, established as the major driver of
motor dysfunction in People with Parkinson’s (PwP), primar-
ily affects the nigrostriatal pathway and the striatal-cortico-
thalamic circuit (Houk and Wise 1995; Rivlin-Etzion et al.
2006; van Eimeren and Siebner 2006). The symptoms of PD
are caused by a dysfunction of these large-scale brain net-
works. A canonical pathophysiological model proposed
that PD symptoms reflect hypoactivation of the direct and
hyperactivation of the indirect striato-cortical pathways
(Alexander et al. 1986). In PD animal models activation
of the direct pathway has been demonstrated to reduce
freezing, increase locomotion and prevent bradykinesia
(Kravitz et al. 2010). By contrast, excitation of the indirect
pathway elicits a parkinsonian-like state via relay regions
including the external parts of globus pallidus and subtha-
lamic nucleus (Purves 2012).
Over past decades, a growing number of motor-tasked neu-
roimaging studies have identified differences in the functional
covariance pattern of regional brain activity and motor task
execution in PwP from that in age-matched healthy controls.
This functional reorganization of brain networks in PD has
been suggested to be a combined outcome of the disease
effect and the subsequent compensatory mechanisms. To
compensate for failure of the normal pathways (Kalmar
et al. 2011; Samuel et al. 1997; H. Yu et al. 2007), alterna-
tive motor loops are thought to be recruited in order to
maintain the performance of complex movements (Mallol
et al. 2007).
Although several motor functional MRI (fMRI) studies sug-
gested that the striatum and associative motor cortex are gener-
ally involved in the functional abnormality andmay participate in
compensatory functional reorganization in PD, there is a lack of
consistency in the activation changes described in these regions.
These inconsistent results might be associated with study-wise
differences in features including task paradigms, imaging acqui-
sition and/or analysis methodologies and patient characteristics
(e.g. Bon^ or Boff^ status and Parkinsonian phenotype) or varia-
tion in power. PD is characterised by a dopaminergic deficit and
there is strong clinical evidence for the efficacy of dopamine
replacement therapies using the amino acid L-3, 4-
dihydroxyphenylalanine (L-DOPA) and dopamine agonists
(Buhmann et al. 2003; Haslinger et al. 2001; Jenkins et al.
1992; Rascol et al. 1994). In addition to clinical motor improve-
ment, the beneficial effects of dopamine replacement have been
mechanistically demonstrated in a number of neuroimaging stud-
ies on movement-related brain activation (Agosta et al. 2014;
Kwak et al. 2010; Nandhagopal et al. 2011; Wu et al. 2009).
However, it is conceivable that not all alterations of motor brain
activation observed under dopamine replacement therapy reflect
the restorative effects of the treatment. The activation patterns
seenmay also highlight enhanced dopamine-dependent compen-
satory mechanisms or demonstrate the neural underpinning of
adverse drug effects (Brotchie and Fitzer-Attas 2009; Fahn
et al. 2004; Holloway et al. 2000; PS 2002; Zigmond et al. 1984).
A further important cause for the discrepancies of neuro-
imaging results could be variation in the probed motor pro-
cesses, such as motor preparation and prediction for intention-
al actions. It is well known that PwP have difficulty with self-
initiating movements, whereas external cues/marks can help
improving their motor performance. In fact, studies have in-
dicated that in externally-triggered paradigms, brain regions
involved in anticipation and motor preparation were more
likely to be activated due to the regularity and predictability
of the incoming stimulus, whereas self-initiation or self-
selected paradigms engage with a different set of brain areas
that contribute to the ‘volitional action system’ (Jahanshahi
et al. 1995).
Another disputed issue is the effect of alternative pathway
recruitment to compensate for the depletion of striatal dopa-
mine. More than two decades ago, a classical dopaminergic
neuronal adaptive strategy was proposed, suggesting that
these cells within the nigrostriatal system initiated a series of
neurochemical changes to rectify the loss of dopamine-
involved homeostasis caused by the disease (Bezard et al.
2003). However, several electrophysiological experiments
on animals have challenged this model by showing that
the motor symptoms could be restored without increasing
the level of extracellular dopamine (Ponce and Lozano
2010). Therefore, it is still unclear how the motor system
restores motor function after degeneration of dopaminergic
neurons.
Coordinate based meta-analysis of functional neuroimag-
ing studies allows to synthesize the imaging literature on brain
disorders, to investigate common patterns and moderator fac-
tors addressing the typically low power of original studies.
Problematically, early implementations of coordinate meta-
analysis tools were themselves prone to false positive results.
A previous meta-analysis of motor activation studies in
Parkinson’s used this method and found that abnormal activa-
tion in the putamen seems to be the source of motor impair-
ment in PD, which can be improved by dopaminergic medi-
cation. However, their meta-analysis does not provide the ev-
idence to account for the heterogeneity in existing reported
activation differences between patients and healthy controls
and they concede that their proposed mode of movement se-
lection (motor timing and selection) failed to explain this con-
dition. In addition, the approach of their correlation analysis
(activation deficiency and motor impairment) without
correcting for multiple voxel-wise correlations needs to be
reconsidered when interpreting the results (Herz et al. 2014a;
Tench et al. 2013). In this study, we aimed to investigate the
possible reasons for reported controversies of abnormal motor
Brain Imaging and Behavior
activation in PD.We provide a robust synthesis of evidence of
PD-related alterations of motor activation that confirms the
deficiency of motor activation in the left posterior putamen
in PD. We also present new convergent brain imaging evi-
dence that informs on the neural basis of motor impairment
in Parkinson’s disease, involving motor intention, disease se-
verity, and drug effects. As one of the most common deep
brain stimulation approaches, the efficacy of STN DBS ther-
apy on the clinical outcomes of motor function has been dem-
onstrated by meta-analyses (Kleiner-Fisman et al. 2006;
Perestelo-Perez et al. 2014). However, it still remains under
debate of how the DBS STN exerts the improving effect on
PD patients. The present meta-analysis provides additional
evidence about the underlying mechanism by taking account
of the medication status, stimulation side and the experimental
condition (i.e. during motor task or resting). Additionally, we
compared the DBS effect with the dopaminergic medication
effect to investigate the commonality and difference between
the two interventions.
To improve the quality of the meta-analysis we aimed for
adequate homogeneity in functional results by only including
upper extremity motor task studies, also assessed the role of
experimental factors and used quality control tools from an
improved novel meta-analysis technique in order to detect
coordinate reporting errors (Tench et al. 2013). We also mir-
rored the coordinates from left to right based on the laterali-
zation of the motor activity in normal HC to study the disease
laterality in PD. In this study, we did not include other surgical
interventions such as pallidotomy, and thalamotomy because
few neuroimaging studies reported activation coordinates,
preventing spatial synthesis and meta-analysis. In addition,
unlike DBS which has strong and consistent clinical evidence
of definite efficacy on motor impairment (other than gait ki-
nematics) for PD, the non-invasive brain stimulations, includ-
ing transcranial magnetic stimulation (TMS) and transcranial
direct current stimulation (tDCS) still need to be validated in
clinical settings, and thus studies applying those methods were
excluded (Benninger and Hallett 2015; Shirota et al. 2016;
Strafella et al. 2003a, 2006).
Materials & methods
Literature search and selection
We undertook a literature search of Medline, ScienceDirect and
Neurosynth databases for functional Magnetic Resonance
Imaging(fMRI) and/or Emission Tomography (SPECT or
PET) studies involving people with idiopathic Parkinson’s
disease and healthy volunteers published in English using
the following keywords: BParkinson’s disease^ [Medical
subject heading(MeSH)], Bfunctional magnetic resonance
imaging^ Or Bfunctional MRI^ Or BfMRI^, BPositron-
Emiss ion Tomography^ [MeSH] , BTomography,
Emission-Computed, Single-Photon^ [MeSH], Motor task
or Movement task, BDeep brain stimulation^ Or BDBS^.
This search conducted by three independent authors result-
ed in 2496 studies with searching time as BAll Year^ till
18th January 2017.
Following pre-specified inclusion and exclusion criteria,
we grouped all the experiments from healthy controls (HC),
people with Parkinson’s (PwP) studied on or off medication
(PwP onMed or PwP offMed) into seven main categories
(Table 1).
Inclusion and exclusion criteria
Inclusion criteria
i. subjects were either people with idiopathic Parkinson’s
disease or healthy controls
ii. functional neuroimaging methods included functional
MRI, PET or SPECT
iii. studies using motor task involving the upper extremities
iv. activation clusters of task versus rest (baseline) contrast
were reported for single group studies (HC, PwP) or ac-
tivation clusters of group differences were reported.
v. the coordinates of the activated foci were reported in either
Talairach or Montreal neurological institute (MNI) stan-
dard space.
vi. studies in which deep subthalamus brain stimulation
(DBS) were conducted.
Exclusion criteria
i. article type was not original full research article of func-
tional imaging during motor task
ii. studies investigated motor tasks involving cognitive task
during motion experiments (i.e. motor learning), visuo-
motor coordination, task involving body parts outside up-
per extremities, gesture task specific to object, motor im-
agery task, and studies in which the healthy volunteers
performed tasks that did not match with PD within the
same articles.
iii. studies only applied and reported the results of brain
functional connectivity, multivariate analyses or covari-
ance analyses
iv. studies reporting only ROI-based analysis
v. studies in which the coordinates were not reported
vi. studies where scanning coverage does not include top of
the brain and most part of the cerebrum
vii. studies which applied non-invasive brain stimulation i.e.
TMS and tDCS or other surgical intervention, such as
pallidotomy, thalamotomy and GPi DBS.
viii. Those with less than 5 participants were included.
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Data extraction and quality checks
Coordinates of the peak focal activations, Z(t) scores, popula-
tion numbers, modality approach, and contrast (group) condi-
tion were extracted for each study (see Table S1 in
Supplementary Information [SI] for more details) and entered
into the database by two investigators independently and were
checked by the other individual for quality control purposes.
There were no discrepancies between investigators. In addi-
tion, we merged articles and removed duplicate reports that
used the same subjects to prevent bias of results towards any
particular population. This was carried out following a check
of duplicated reported coordinates as implemented in (Tench
et al. 2013) http://www.nottingham.ac.uk/research/groups/
clinicalneurology/neuroi.aspx [30] .
Coordinate based meta-analysis (CBMA)
The extracted coordinates were fed into a series of CBMA
after a systematic data quality check as previously described
(Tench et al. 2013). More detailed description of the method
for generating activation likelihood estimates can be found
elsewhere (Tench et al. 2013). To briefly summarize, each
reported coordinate of significant activation as well as deacti-
vation foci from every included publication was modelled as a
spatial 3D truncated Gaussian distribution. Importantly the
full width half max was automatically modified to account
for the number of studies included in the analysis; this helps
to prevent false positive results for large numbers of studies,
and false negatives for small numbers of studies (Tench et al.
2014). As the frequency of a given focus being reported in-
creases, the likelihood of activation enhances. We then de-
rived all the significantly activated regions by thresholding
the likelihood of activation at a value obtained from a
nonparametric permutation test, corrected for multiple com-
parisons (Tench et al. 2013, 2014). The results of all the anal-
yses are presented in Talairach space.
Contrast meta-analysis (CMA) and omnibus test
To analyse spatial differences in activation pattern between
groups, a contrast meta-analysis (CMA) was performed
whereby coordinates from any two groups are compared using
a permutation test. CMA is prone to type II error due to very
stringent p-values after controlling for many statistical tests.
Hence, we complemented CMA by an omnibus test that is
more sensitive for detecting subtle differences that spread
across regions of the activation pattern (Tench et al. 2014),
which may be unrevealed by CMA. False positive results
are controlled, using the false cluster discovery rate, at a level
of 0.1 to further mitigate against the low power of CMA
(Tanasescu et al. 2016).
Meta-analysis of contrast (MAC)
Studies directly reporting contrasts between HC and patient
groups lend themselves to aggregate these contrast maps (me-
ta-analysis of contrasts [MAC]), thereby allowing to analyse
both spatial differences in activation and in differences in local
activation height. False positive results are controlled, using
the false cluster discovery rate at a level of 0.05.
Design of group contrasts and correlation analysis
Demographic and experimental factors
Prior to conducting all the meta-analyses, in an attempt to
maximise power but reduce unwanted heterogeneity between
Table 1 Information of the fMRI and PET studies for different meta-analyses
Groups/contrasts Contrasts, group details Papers Experiments
(No.)
Extracted Coordinates
(No.)
Subjects (No.)
For coordinate based aggregation meta-analysis (CBMA) and respective contrasts between groups (CMA)*
1 Activation,
PwPoffMed
15 23 203 149
2 Activation,
PwPonMed
5 6 37 49
3 Activation, PwP 20 29 240 198
4 Activation, HC 61 110 1406 698
For meta-analysis of contrast (MAC) ** reported between PwP vs. HC
I vs II Activation
PwPonMed vs.
PwPoffMed
7 9 30 67 PwP
II vs III Activation,
PwPoffMed vs. HC
26 34 383 331 PwP
I vs III Activation,
PwPonMed vs. HC
4 5 44 45 PwP
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study designs, we first examined potential nuisance factors
from laterality (contralateral vs. ipsilateral to right-handmove-
ment), age (≤30 years vs. ≥60 years), sex (male vs. female),
and potential influence of intention-related process on motor
task, including the self-initiated (SI) and externally-triggered
(ET) movement. Lateralization was examined in HC and PwP
groups after mirroring the coordinates obtained from motor
experiments using left upper limb to the opposite side, given
the majority used right upper limb, to minimize laterality
effects.
The effect of Parkinson’s disease
One of the main aims was to identify an experimentally in-
variant disease specific pattern and to investigate its interrela-
tion with disease severity. We undertook the following group
and subgroup comparisons: CMA and omnibus test were per-
formed contrasting PwP vs. HC, PwPoffMed vs. HC, and
PwPonMed vs. HC.Meta-analysis of contrast (MAC) was con-
ducted based on PwPoffMed > HC and PwPoffMed < HC. In
addition, we correlated the off-med UPDRS score as marker
of the motor impairment with the standardized activation of all
the significant areas. To normalize the difference of the cohort
size, which has not been taken into account in the previous
analysis (Herz et al. 2014a), we divided the reported Z scores
of each coordinate by the square root of the subject number. Z
values of studies that did not contribute to the respective re-
gions were removed. Then we applied a weighted linear re-
gression analysis and the outcomes of the correlation between
the Z scores and UPDRS-III scores were thresholded at
P < 0.05.
The effect of dopamine replacement therapy
For assessing the dopaminergic medication effect, we investi-
gated PwPonMed vs. PwPoffMed, PwPoffMed vs. HC, and
PwPonMed vs. HC using CMA.We also performedMAC anal-
ysis on the subgroup comparison PwPonMed > PwPoffMed,
PwPonMed < PwPoffMed, PwPonMed > HC, and PwPonMed < HC.
The effect of deep brain stimulation
To better understand the therapeutic mechanism underlying
deep brain stimulation in PD, we synthetized the neuroimag-
ing evidence on deep brain stimulation. Due to the limited
number of reported articles with spatial coordinates in the
effect of globus pallidus DBS (GPi DBS) on motor function
in PD, we only included studies about STN DBS. We com-
pared DBSoff vs. DBSon during hand movements, DBS ef-
fect during two experimental conditions (duringmotor task vs.
resting) on account of medication status (off medication), and
stimulation side.
The effect of deep brain stimulation versus dopamine
replacement therapy
To investigate the difference between the effects of two treat-
ments, we compared PwPonMed vs PwPoffMed and DBSon
vs DBSoff using CMA analysis and omnibus test.
Results
After primary screening, our first search identified 375
articles, of which 126 studies were included, involving
1024 HC, and 657 PwP (222 motor task experiments)
(Fig. 1, Tables 1 and 2). PwP had an average reported
UPDRS motor score of 24.7 (±9.1 standard deviation),
reported Hoehn and Yahr scale median: 1.8(interquartile
range, 1) and disease duration ranging from 1.8 to 12.9
(mean age ± standard deviation, 6.6 ± 3.6) years. The
mean age of the HC included in this study was
35.5 years (±16.0, standard deviation) with a subgroup
of elder HC (mean age, 64.0 ± 2.6 years).
Potential demographic or experimental factors
affecting the motor activation pattern
No significant age difference was found using the un-
paired t-test, but there was a marked difference between
the HC in PD-related studies and those from articles
that simply investigated the brain activation pattern in
HC during motor tasks (p < 0.05 based on omnibus
test). This allowed us to examine the normal aging ef-
fect on motor task for healthy volunteers. However, we
failed to observe regions of significant differential acti-
vation between young HC and elderly HC during the
motor performance with our CMA analysis when we
selected studies with population of age above 60 years
(elderly) versus those under 30 years (young) as the
criteria. Nevertheless, we were still able to illustrate
the frequency of the regions, such as bilateral SMA,
right premotor cortex, left insula and right cerebellum
that showed significant contribution (p < 0.05) to the
between-group difference (see Fig. S4 in supplementary
material). Furthermore, we used MAC on three articles
that focused on the age effect on brain activation during
motor execution, but none of the reported age-dependent
clusters were found to be consistent across the three
studies.
Neither did we find significant differential patterns
with regard to sex or the Bwhat^ component of inten-
tional action (i.e. what movement or sequence did the
participants choose). However, a few regions were la-
belled to be highly involved in Bwhen^- self-selecting
the moment of execution or not using MAC (Fig. S1).
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We hence pooled all data, but examined the effect of
movement intention by group separately.
Spatial pattern of motor activation in PwP
and healthy controls
CBMA demonstrated a consistent activation pattern in
healthy controls performing motor tasks of the right
upper extremity or looking at flipped results in those
few studies deploying the left upper extremity
(Fig. 2a). The pattern is largely bilateral involving the
extended motor network with some contralateral lateral-
ization. A similar albeit more reduced pattern was ob-
served in PwP (Fig. 2b). Visually apparent differences
in pattern expression can also be seen in the frequency
maps (Supplementary material, Fig. S2), and using the
omnibus test, we found that the global activation pattern
did exhibit a significant between group difference (p =
0.0043). For instance, the HC showed more frequently
reported activation in the putamen, insula, thalamus,
medial frontal gyrus and inferior parietal lobule in both
hemispheres, superior parietal gyrus in the left hemi-
sphere (Fig. S2), but a lower frequency of reported ac-
tivation in the right middle frontal gyrus. Contrast of
meta-analysis (CMA) did not however show consistent
areas of differential activation likelihood between PwP
and HC.
Disease and medication status specific brain
activation contrast
The inability to observe specific differences in activation like-
lihood between patients and controls may have resulted from
heterogeneity caused by medication status. Prior to
performing all the analyses, an omnibus test was used to check
whether the brain activation patterns are different when left vs.
Literature search
Databases: PubMed/MEDLINE, ScienceDirect, 
Neurosynth, Google Scholar
Limits:
-English-language arcles 
-Human studies
Search results (n = 2688)
Arcles screened on basis of tle and 
abstract
Excluded (n = 2313)
-Not idiopathic Parkinson’s disease or healthy 
volunteer
-Surgical intervenon except STN DBS
-Not funconal neuroimaging studies
-Resng state fMRI
-Lower extremity task
-Gait task
-Motor imagery task
Excluded (n = 249)
Included (n = 375)
Full arcles reviewed and aer 
applicaon of inclusion and exclusion 
criterion
Included (n= 126)
Fig. 1 Flowchart of functional
MRI and PET studies recruited in
the analysis
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right hand was used in the motor tasks. The omnibus test
showed no difference between these two conditions. We then
merged all the studies to increase the sensitivity of detection.
To formally probe any difference caused by the disease when
taking the medication status into account, we also performed a
CMA HC vs. PwPoffMed. Though no difference of activation
Table 2 Meta-analysis of group
contrasts (MAC) using activation
likelihood estimates
Hemisphere Brain region Brodmann Area Coordinates (x y z) P value
PwPoffMed <HC
Right Lentiform Nucleus Putamen 21.2 5.6 5.2 0.000195
Left Medial Frontal Gyrus BA 6 −6.0 -18.0 51.0 0.001314
Left Brainstem * Subthalamic Nucleus −10.7 -13.7 -3.4 0.000464
Left Lentiform Nucleus Putamen −23.3 -2.4 11.8 0.000645
Right Thalamus * 13.8–5.6 4.0 0.000607
Right Lentiform Nucleus Medial Globus Pallidus 16.0–4.4 1.6 0.00156
PwPonMed>
PwPoffMed
Left Superior Frontal Gyrus BA 6 −16.0 16.0 58.0 0.004158
Right Middle Frontal Gyrus BA 6 32.0 0.0 50.0 0.005447
Right Lentiform Nucleus Putamen 24.9–3.8 4.3 0.005395
Left Lentiform Nucleus Putamen −25.1 -3.5 3.5 0.002026
Left Claustrum * −32.5 -10.9 2.7 0.008842
PwPonMed>HC
Left Medial Frontal Gyrus BA 6 −3.6 -6.8 55.8 0.006447
Left Precentral Gyrus BA 4 −31.4 -22.1 59.3 0.003342
Left Precentral Gyrus BA 6 −35.1 -12.6 58.3 0.008474
PwPonMed<HC
Right Postcentral Gyrus BA 2 27.7–33.8 61.0 0.0017
Right Cerebellum * 21.4–47.9 -25.1 0.00632
Fig. 2 a Aggregated upper
extremitymotor-related activation
pattern in healthy controls (n=686
subjects, n=109 experiments,
FCDR corrected p<0.05) and b in
people with Parkinson’s using
CBMA color-coded according to
medication state (red: on medica-
tion, n=49 subjects, n=6 experi-
ments, FCDR corrected p<0.05,
green: off medication, n=138
subjects, n=22 experiments)
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likelihood was revealed, the omnibus test showed significant
differences of global activation pattern (P = 0.03). Moreover,
MAC found that PwP off medication displayed consistently
reduced activation strength compared to HC in the bilateral
putamen, left subthalamic, left medial frontal gyrus and right
thalamus (p < 0.002) (Fig. 3 and Table 2) when undergoing a
motor task.
Correlation between brain activation and motor
impairment in PwPoffMed
We investigated the relationship between the estimated local
activity and severity of motor impairment using weighted
meta-regression based on reported mean UPDRS-III score in
22 (17 fMRI, 5 PET PwPoffMed) studies. Analysis was limited
to significant clusters for all PwPoffMed vs. HC contrasts listed
in Table 2. The motor score was found to be negatively cor-
related with the likelihood of activation in the left SMA (see
area outlined by black dots in Fig. 4 left) only (rho = −0.627;
p = 0.044; Fig. 4 right), suggesting that this regional activation
decreases in PwPoffMed as the motor impairment increases.
Effect of dopaminergic medication on motor
activation in PwP
To aggregate the direct within-subject effect of dopaminergic
treatment, MAC comparing PwPonMed with PwPoffMed
was performed. We identified several regions with motor ac-
tivation consistently augmented by dopaminergic medication
(PwPonMed > PwPoffMed): left superior frontal gyrus, right
middle frontal gyrus, bilateral putamen and left claustrum
(Fig. 5 and Table 2). There were no regions with reduced
activation during the on medication state (PwPonMed
<PwPoffMed).
To assess any possible additional effect of dopaminergic
medication on brain activation, we also undertook contrasts
between PwPonMed vs. HC using omnibus tests, CMA and
MAC. The omnibus test supported an overall activation dif-
ference between groups (P = 0.04), but CMA did not reveal
significant spatial differences of activation likelihood.
However, MAC revealed consistent areas of both decreased
and increased motor activation strength in medicated patients:
PwPonMed < HC contrast showed decreased activation in the
right postcentral gyrus and right anterior lobe of cerebellum
(p < 0.05) (clusters in blue in Fig. 6 and Table 2); PwPonMed
> HC contrast found increased activation in the left precentral
gyrus and medial frontal gyrus (clusters in red in Fig. 6 and
Table 2).
Effect of deep brain stimulation on brain activation
with off medicated PwP
Our MAC analysis results on brain activation triggered by
STN DBS was not different between hand movement and at
rest. Even the most sensitive omnibus test did not show any
difference due to movement status. Also, there was no effect
of DBS (DBSon vs DBSoff) during hand movement.
Therefore, to increase the sensitivity of detecting the potential
effect of DBS, we combined all the studies regardless of the
movement condition, and we revealed the main effect of the
Fig. 3 Reduced motor activation
in PwP off medication vs. healthy
controls (Meta-analysis of
contrasts, n=34 experiments,
n=331 patients vs. 327 controls,
FCDR corrected p<0.05)
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bilateral STN DBS as an increased activation of left thalamus
(i.e. ventral lateral nucleus), and left globus pallidus (DBSon
vs DBSoff). Compared with the DBS-off condition, activity in
the left SMA, and M1, and the right culmen were reduced
(Fig. 7 and Table 3).
Difference between effect of deep brain stimulation
and dopaminergic replacement therapy on brain
activation
No consistent areas of different activation likelihood were
revealed when comparing the two therapies using CMA or
MAC, but there was a marked difference between the brain
activation patterns in those two approaches duringmotor tasks
(p < 0.05 based on omnibus test).
Self-initiated versus externally triggered movements
in Parkinson’s disease
CMA showed that external-paced motor task did not differ in
the brain activation pattern from self-paced tasks in all the
single groups, whereas in PwPoffMed > HC the supplementary
motor area was consistently enhanced in the condition of self-
paced task (Fig. S3).
Discussion
Using coordinate based meta-analysis, we report consistent
spatial activation patterns, but differential activation contrasts
in a large group of healthy controls and people with PD and its
moderation by current treatment strategies.We provide insight
into the motor network alteration induced by Parkinson’s dis-
ease, its partial restoration by dopaminergic treatment, modu-
lation by DBS and overcompensation resulting from
medication.
Neural activation pattern in simple upper extremity
motor tasks in controls
Regions including primary and supplementary motor and
premotor cortex, bilateral putamen, medial frontal gyrus,
STN, thalamus, and medial globus pallidus (GPi) in both
hemispheres as well as anterior bilateral cerebellar
Fig. 4 Left, The co-localization of effects from modifying factors of
SMA/medial frontal gyrus motor activation in PD. Clusters were
thresholded for the sake of illustration. Blue: hypoactivation due to dis-
ease effect (PwPoffMed < HC); Red: hypoactivation in DBS on phase
(DBSon < DBSoff); Green: hyperactivation in self-initiated movement in
PD (SI>ET); and Yellow: hyperactivation due to dopaminergic
medication (PwPonMed>HC) superimposed with black dotted outline
of the medial frontal activation obtained from motor activation in con-
trols. Right, Decreased left medial frontal motor activation with increas-
ing motor severity (Weighted meta-regression of UPDRS-III score and
standardized Z scores of motor activation on PwPoffMed, p<0.05)
Fig. 5 Increased contralateral and
decreased ipsilateral motor
activation in medicated PwP
(Meta-analysis of contrasts; A:
PwPonMed < HC, B: PwPonMed
>HC, 5 experiments, patients
n=45 vs. 44 controls, FCDR
corrected, P<0.05)
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hemispheres were seen in our aggregated activation pattern in
HC. This co-activation pattern involves the known cortical
motor network and subcortical hubs from both the direct and
indirect pathways, thus conforming to simultaneous deploy-
ment even during simple motor tasks, and independent from
external or internal action triggering.
Disease specific network alterations of basal ganglia
system in PD
The aggregated motor co-activation pattern in PwP did not
reveal consistent areas of altered activation likelihood in the
whole group or in the off medication subgroup. However, the
activation strength assessed by aggregation of reported con-
trasts was consistently reduced in the bilateral basal ganglia
(i.e. putamen), left medial prefrontal cortex (SMA), left subtha-
lamic nucleus, right thalamus and right globus pallidus. This is
only partially in line with the previous meta-analysis, which
demonstrated increased activation in left superior parietal lob-
ule and decreased in right putamen. Our results imply that the
motor activation response of the left SMA and putamen of both
hemispheres is reduced in the hypodopaminergic state. We did
not find evidence for compensatory hyperactivity of motor cir-
cuitry to mitigate the loss of motor activation. This hypothesis
may be further evidenced by the lack of correlation between
putaminal activation and disease severity, which is again differ-
ent from the previous meta-analysis (Herz et al. 2014a). This,
however, is well in line with evidence from previous clinical
and dopaminergic imaging findings, showing that dopamine in
the putamenmust be degraded to approximately 50–60% of the
normal level before patients are diagnosed, and that loss of
dopaminergic neurons might be complete during early disease
stages resulting in a ceiling effect during later disease stages
(Asanuma et al. 2006; Bruck et al. 2006; Nurmi et al. 2001;
Fig. 6 Increased motor activation
due to dopamine-replacement in
PwP (Meta-analysis of contrast
on medication > off medication
state, 9 experiments, and patients
n=67, FCDR corrected, P<0.05)
Fig. 7 Increased left thalamus
and decreased left primary motor
cortex and SMA in off medicated
PwP regardless of hand
movement during high frequency
bilateral STN DBS (Meta-
analysis of contrasts; Red: DBSon
> DBSoff, Blue: DBSon <
DBSoff, FCDR corrected,
P<0.05)
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Politis 2014). Consequently, this may make the task-related
activity of the whole putamen a less sensitive measure to reflect
the motor impairment, whereas other non-dopaminergic struc-
tures, such as SMA correlated more strongly with clinical mo-
tor scores (see more explanation in the section associated with
the role of SMA).
When interpreting the observed impaired neurovascular
activation against predictions of the classical model of hyper-
active indirect and hypoactive direct motor networks, a num-
ber of explanatory and moderating regional and global factors
have to be considered. Disease-related regional changes in
brain activity at rest are known to affect task-induced BOLD
activity and high baseline activity may result in reduced
motor-induced activation. Additionally, without access to con-
current motor task performance data, we cannot assess to
which degree the changes of motor activation reflect differ-
ences in task performance. Previous studies showed enhanced
ROI-to-ROI functional connectivity between SMA and puta-
men based on a resting-state fMRI in off-medication patients
(Kwak et al. 2010; R. Yu et al. 2013). Hypoactivity of the
putamen and motor-related cortex (i.e. SMA) may provide
additional evidence by showing that their increased connec-
tivity may be attributed to the decreased activation of both
regions. Our results may well reflect hypodopaminergic
changes of the motor circuit, which involves corticostriate
projections from the premotor cortex to the putamen.
Our results also showed significantly reduced activation in
the basal ganglia pathways, such as the globus pallidus, sub-
thalamic nucleus and thalamus, suggesting that these regions
are involved in the pathological process. Despite the fact that
M1 did not show significantly decreased activation, it showed
nominally higher reported frequencies than for the rest of the
brain (also see Fig. S3). This may imply an alternative and
more parsimonious explanation: the observed unidirectional
alterations in PD can be seen to add to the critical evaluation of
the classical model of basal ganglia circuits, that led to a more
advanced notion that motor-related behavior is a result of a
complex interaction between these two pathways, suggesting
that network integration of all basal ganglia circuits subserve
co-ordinated motor activity (Calabresi et al. 2014; Jahanshahi
et al. 2015). Recent studies have demonstrated a hyperdirect
cortico-subthalamo-pallidal pathway, which has been viewed
as the quickest approach for accessing motion output. It has
been shown to be operating via a complicated combination of
suppression, excitation and disinhibition (Jahanshahi et al.
2015; Nambu et al. 2002). Therefore, along with the mounting
pathophysiological evidence (Bergman et al. 1994; Goldberg
et al. 2002; Hammond et al. 2007; Wichmann et al. 2011), the
presented imaging evidence suggests that the motor deficits in
PD may be better explained by the inability to activate the
striato-cortical network than by simple hyperactivation of
the indirect pathway.
The dopaminergic restorative pathway in Parkinson’s
disease
Dopaminergic drugs are known to play a critical role in the
functional remapping of the brain during motor execution.
Compared to the number of studies on PwP off-medication,
fewer studies reported the on-medication condition to avoid
the confounding effect of drugs (see Table S3 in suppl material
for the types of DRT). However, these studies offered us the
possibility to assess the differential brain activation effect
of dopaminergic medicat ion. Our meta-analys is
(PwPonMed > PwPoffMed) revealed that dopaminergic medi-
cation significantly increased motor activation in the supe-
rior and middle frontal gyri. We also found increased acti-
vation in the bilateral putamen-related activation, demon-
strating that dopamine induces frontal hyperactivation and
largely restores the deficient motor activation of the puta-
men in reported cohorts of PD. This effect partially contra-
dicts a previous meta-analysis reporting unilateral
putaminal activation but no cortical hyperactivation due to
dopamine replacement (Herz et al. 2014a). The lack of pre-
vious observation of this effect can be explained by a larger
number of included studies and an improved meta-analytic
methodology in our study. Hyperactivation of the middle
frontal gyrus has been proposed to be related with the
Table 3 Meta-analysis of group
contrasts (MAC) for STN DBS
using activation likelihood
estimates
Hemisphere Brain region Brodmann Area Coordinates (x y z) P value
DBSon >DBSoff
Left Thalamus * −11.0 -12.0 0.0 0
Left Thalamus Ventral Lateral Nucleus −10.0 -14.0 4.0 0
Left Thalamus Ventral Lateral Nucleus −13.0 -15.0 6.0 0
Left Lentiform Nucleus Lateral Globus Pallidus −18.0 -10.0 6.0 0.000023
DBSon <DBSoff
Left Medial Frontal Gyrus BA 6 −7.0 -14.0 51.0 0.003169
Left Precentral Gyrus BA 4 −50.0 -12.0 41.0 0.001468
Right Culmen * 4.0–60.0 -8.0 0.002331
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attention networks, by switching attention between the en-
dogenous controlling processes and external stimulus
(Corbetta et al. 2008; Japee et al. 2015). The amplified
activation in this region indicates the drug effect may re-
store and strengthen the attentional process to facilitate the
role of superior frontal gyrus in coordination with the exe-
cution of sensory system.
The functional role of basal ganglia subregions in PD
and region-specific effect of dopamine replacement
To further discern the functional deficiency and the restorative
localization in PwP, we overlaid our detected activation clusters
for disease on a striatal atlas based on probabilistic diffusion
tractography defining limbic, executive and sensorimotor sub-
regions (Tziortzi et al. 2014). This illustrates that most of the
deactivation areas are linked to the executive (dark green in
Fig. 8) and sensorimotor cortex (pink in Fig. 8) in PD. As
expected, the limbic basal ganglia subregions were least affect-
ed. It is worth noting that dopamine replacement restored the
disease-related reduction of activation in the putaminal subre-
gion that connects to the executive and motor cortex. This
conforms to the clinical observation of improved motor func-
tion after dopaminergic treatment (Buhmann et al. 2003;
Haslinger et al. 2001; Jenkins et al. 1992; Rascol et al. 1994).
These findings are also supported by recent resting state fMRI
studies showing that spontaneous activity in the posterior pu-
tamen was uniquely linked to cortical motor activity, while the
anterior part appears more connected to the pre-supplementary
motor area and anterior cingulate cortex (Hacker et al. 2012;
Helmich et al. 2010). Moreover, previously shown diminished
functional connectivity between the posterior putamen and in-
ferior parietal cortex in PD patients is consistent with our find-
ing of co-deficiencies in putamen and inferior parietal lobule
based on frequency maps (Fig. S2). Furthermore, our result of
predominant posterior putaminal restoration of dopamine re-
placement in PD is supported by molecular imaging such as
18F-DOPA PET that mainly link the dorsal caudal putamen
with the decline of dopaminergic function (Fearnley and Lees
1991).
The dopaminergic effect on spontaneous brain
activity in PD
Unlike the dopaminergic effect onmotor activation, performing
a meta-analysis of the drug effect on brain spontaneous activity
remains hampered by the heterogeneity of analytical proce-
dures and methods, and the lack of coordinate’s details and
decent number of articles. For instance, the evidence of the
direct influence of DRT on cerebral perfusion at resting-state
is still relatively scarce and inconsistent. Nevertheless, a very
recent observation of cerebral blood flow (CBF) using MRI
arterial spin labelling technique showed hypoperfusion in the
inferior frontal gyrus in PD after dopaminergic administration,
similar to the findings from a previous PETstudy (Berding et al.
2001; Lin et al. 2016). Other regional CBF changes have been
also identified in striatal-thalamo-cortical circuits (Hershey
et al. 2003; Hirano et al. 2008; Kobari et al. 1995). But no
Fig. 8 Co-localization of altered
subcortical motor activation due
to disease (blue: hypoactivation
PwPoffMed<HC) and STN DBS
effects (green: hyperactivation
DBS off < DBS on) overlain on
structural connectivity atlas. The
boundaries of executive (green),
limbic (brown) and sensorimotor
(pink) are delineated. Thalamic
nuclei are outlined in black.
Noticeably, no activation differ-
ence was shown in the striatal re-
gions posterior to the dopaminer-
gic treatment (PwPonMed >
PwPoffMed)
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confirmed correlation between daily uptake dose of Levodopa
and hypoperfusion has been provided so far (Liepelt et al.
2009). On the other hand, despite those reported focal CBF
changes, global CBF at rest is not altered significantly as a
consequence of medication (Hershey et al. 2003; Hirano et al.
2008; Jenkins et al. 1992; Melamed et al. 1986). However,
using the more advanced analytical approaches, including
seed-based, network-based, graph-based analyses, and effective
connectivity with resting-state fMRI, investigators showed that
DRT might modify the intrinsic functional disorganization of
the brain via the sensorimotor network and cortico-striato-
thalamic network [see review (Tahmasian et al. 2015)].
The effect of deep brain stimulation (STN DBS)
on motor activation
This present meta-analysis for the first time investigated the
mechanistic imaging studies to explore the role of pathway
changes both at rest and under manual activation. But no dif-
ferential effect of DBS was unveiled comparing the brain acti-
vation patterns in those conditions. Nevertheless, by combining
all the STNDBS results together regardless of hand movement,
we compared the DBSon vs DBSoff, which showed hyper-
activation in the left thalamus and GP, and hypo-activation in
the left SMA,M1 and cerebellum in PwPoff-med with indications
for the efficacious implementation of DBS, which is in line with
the classical indirect basal ganglia pathway. This suggests a
predominantly down-regulatory cortical effect of STN DBS,
and this may restore cortical dysfunction via inhibiting the path-
ological and/or side effect of pharmacological over-activation.
Surprisingly, we did not observe significant changes of brain
activation in some expected regions within the basal ganglia
thalamo-cortical motor circuit, such as the putamen and/or
substantia nigra, which again may imply a more complicated
interactive basal ganglia network. However, a simple dilution
effect cannot be excluded since we merge the studies regardless
of the movement status to increase the statistical power.
Therefore, more evidence with advanced analysis (i.e. function-
al connectivity) is needed to further tackle this question.
Commonalities and dissociations of the effects
of deep brain stimulation (STN DBS) and DRT
on motor activation
Direct stimulation in the deep brain nuclei is an alternative to
levodopa treatment for modulating the abnormal STN activity
with evidence shown in improving the motor symptoms. The
brain oscillation studies also showed that this improvement of
motor performance might be related to the increased frequency
of beta-burst induced by both levodopa and adaptive DBS
(Tinkhauser et al. 2017a, b). Fig. 9 illustrates the functional con-
nectivity from STN and dopaminergic pathway obtained from
neurosynth (http://www.neurosynth.org/analyses/). Our omnibus
test showed a significant difference between the activation
patterns between the effects induced by the two treatments.
Interestingly, our meta-analysis on STNDBS effects demonstrat-
ed increased activity in the thalamus and GP, and decreased
activity in motor regions, whereas up-regulation in frontal gyri
and the putamen was illustrated due to drug effect. In contrast to
the direct increase of putaminal activation induced by the DRT in
line with dopamine increase, the evidence for DBS highlights a
restorative mechanism for the neuromodulation that targets the
deficiency in the striatal-thalamic circuit in PD. This is consistent
with the previous physiological finding that STN-DBS does not
increase dopamine production (Benazzouz et al. 2000) although
animal models demonstrated accelerated firing rate in SN (Hilker
et al. 2003; Nakajima et al. 2003; Strafella et al. 2003b). Taken
together, dopaminergic pharmacotherapy and STN DBS may
achieve therapeutic efficacy via manipulation of different regions
in similar networks (Eidelberg 2009). But this difference could
also be caused by the different characteristics of patient popula-
tions, since the PwP who underwent STN DBS were more
Fig. 9 The functional connectivity from STN and dopaminergic pathway obtained from neurosynth (http://www.neurosynth.org/analyses/). Green:
dopaminergic pathway; and red: undirected functional connectivity results based on the seed in subthalamus
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advancedwith eithermotor fluctuation or LID,whichmay not be
simply imposed by the loss of dopamine (Hammond et al. 2007).
This abnormal SMA in the DBS-on condition, therefore, may
imply an inextricably reorganized network related to both the
external electrical stimulation and disease.
In addition to the dysfunction of the basal ganglia-thalamic
pathway, changes in the cerebellum have been reported in PwP
when DBS was on. In our meta-analysis, both HC and PD
demonstrated cerebellar activation (Fig. 2a and b) and we failed
to find a significant pattern difference in both cerebella in
PwPoffMed compared to HC. Yet, when we examined its differ-
ential activation for PwPonMed versus HC (PwPonMed <HC), the
anterior lobe of the right cerebellum showed a significant acti-
vation defect in patients after medication. Besides the variation
of studies recruited for the two groups, one possible explanation
for these findings might be that the cerebellum was not activat-
ed as much in the on-medication as it was in the off-medication
condition in order to compensate for the drug-induced effects.
This may also be supported by the suppressed activation of the
culmen in PD off-med when DBS is efficacious.
The cortical mechanism for impaired sensorimotor
integration in PD
Besides the subcortical areas and cerebellum, our MAC also
demonstrates activation differences in a collection of cortical
regions in PD. For instance, different from the fact that no
cortical region was localized in previous analysis (Herz et al.
2014a), we identified consistent left SMA hypoactivation in
PwPoffMed and increased activation in the same region follow-
ing medication (PwPonMed > HC), but reduced activation when
STN DBS was on. This may imply that the restoration of cor-
tical premotor activation in PD may be a combination of the
increased activation during movement and a reduced activity
when less voluntary movements are involved. Discrepant from
these findings, Herz et al. showed hypoactication of left M1 in
PwPonMed < HC, while we show hyperactivation of left M1
gyrus (PwPonMed > HC) and hypoactication of ipsilateral
postcentral gyrus (PwPonMed < HC). These two regions are
known to be involved in both motor processing and somato-
sensory function, such as tactile and proprioceptive processing
(Pleger et al. 2003). Their opposite activation changes point to
dysfunctional bi-hemispheric integration of sensorimotor net-
works which might be associated with enhanced inhibition
from the other hemisphere in the presence of overcompensated
medication effect.
The possible mechanism of levodopa-related
over-compensation
L-dopa treatment can improve bradykinesia, but has a risk of
inducing drug-related involuntary movements (Poewe et al.
1988; Thanvi et al. 2007). Yet the underlying mechanism
has not been fully clarified (see review Vitek 2002;
Anderson et al. 2017; Muthuraman et al. 2017). In addition
to the restorative upregulation of striatocortical network, we
showed hyperactivation in SMA and M1 in medicated pa-
tients, which may be associated with the mechanism of poten-
tial development of LID and/or uncertain vasomotor effect in
the cortical vasculature (Haslinger et al. 2001). Interestingly,
this cortical hyperactivation was not revealed in the previous
meta-analysis (Herz et al. 2014a). Nevertheless, our findings
are supported by an acute levodopa administration study in
drug-naive PD patients showing increased SMA functional
connectivity from suppressed state as indexed by resting state
BOLD signal fluctuations (Esposito et al. 2013). Concordant
imaging studies also reported a predominant levodopa effect
in the SMA and its neighbouring pre-SMA (Deiber et al.
1999; Playford et al. 1992). Additionally, we identified a con-
sistent overshoot of activation in the left M1 in PwPonMed.
This may corroborate the levodopa-related over-compensato-
ry effects in the sensorimotor networks, including the primary
motor cortex (Cerasa et al. 2012; Herz et al. 2014b).
The special role of premotor cortex in PD
The SMA has been commonly reported as the region involved
in motor-related processes. Yet there are some discrepancies
regarding whether this area becomes hypofunctional
(Asanuma et al. 2006; Esposito et al. 2013) or hyperfunctional
(Haslinger et al. 2001; Poisson et al. 2013; Samuel et al. 1997;
Taniwaki et al. 2013) in PD compared to HC during motor
task performance. In the meta-analysis, the SMA exhibits re-
duced activation during the symptomatic stages of PD as we
have described above. Moreover, it is the only location show-
ing significant negative correlation to the clinical severity as
measured by the UPDRS-III motor scores, which is not re-
vealed in previous findings (Herz et al. 2014a ). Interestingly,
few studies of PD gene carriers suggest hyperactivation of
preSMA during the presymptomatic phase (Buhmann et al.
2005; B. F. van Nuenen et al. 2009a, b). This evidence may
point to a varying role of the SMA during disease progression
in the premotor phase and as the motor symptoms deteriorate.
Therefore, the heterogeneity of disease severity and disease
developing phase in different patient populations may contrib-
ute to reported discrepancies in SMA activity levels. Such
controversies could also be explained by its role in self-
initiated movement in patients but not in controls (see supple-
mentary discussions in SI-1). Fig. 8 summarizes the factors
found to modify SMA/medial frontal gyrus activity in PD.
Previous Fluorodeoxyglucose18 PET quantification studies
have also commonly demonstrated hypoactivation of the
SMA in PwP versus HC (Asanuma et al. 2006; Eidelberg
et al. 1994; Huang et al. 2007; Ma et al. 2007). This defect
can be interpreted as the consequence of the reduction in the
positive efferent signal sent from the basal ganglia-thalamo-
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cortical motor circuit secondary to striatal dopamine depletion
(Delong 1990). Interestingly, we found that SMA also showed
hyperactivation after taking dopaminergic medication relative
to HC, which suggests that levodopa may boost the exhausted
compensatory function of SMA motor co-activation.
However, drug-induced SMA overactivation was linked with
a complex abnormal pattern of contralateral motor hyper- and
ipsilateral sensory hypoactivation reflecting functional net-
work disorganization that may lead to LID (Breakefield
et al. 2008; Kojovic et al. 2012).
Limitations and future directions
Every meta-analysis carries over the limitations of the included
primary studies. Hence, the present study could not distinguish
the motor activation patterns in drug-naive patients from those
in patients under long-term treatment because of the limited
reports. We can thus not exclude that residual effects of the
sustained long-term use of dopaminergic drug might have af-
fected the off medication state. Also, the type of dopaminergic
replacement was only partly reported in the medication-effect
studies. The second limitation is the very small sample size of
studies on the brain activation pattern specific to subtypes of
motor impairment due to the recognized underrepresentation of
postural instability and gait disorder patients in imaging studies.
Thirdly, this study examined the lateralization of motor brain
activity pattern in HC and PD. We showed more activation in
contralateral hemispheres albeit bilateral occurrences in differ-
ent MAC analyses (also see SI-2 and Fig. S5 for more discus-
sion). Our lateralised disease-specific pattern and medication
effect may also indicate consequence attributing to a loss of
compensation. However, due to the lack of consistency of the
disease laterality, it is not possible to investigate whether there is
a compensatory effect from the less degenerated side. In the
current study, we focused on the spatial activation pattern of
motor tasks with patients’ right hands. It would be also inter-
esting to reveal the spatial representation of lower limbs, which
is related to the clinical staging.
Despite previous studies having demonstrated the common
activation regions shared by motor imagery and execution
(Baik et al. 2014; Dominey et al. 1995), we decided not to
include motor imagery studies as they involve additional com-
plex cognitive processes. The current data is further limited in
providing confirmatory evidence on the role of the cerebellum
in PD as not all studies achieve complete brain coverage.
Moreover, we studied motor executive abnormality using task
fMRI and PET but did not include resting state BOLD fMRI
and ASL fMRI studies. Functional connectivity changes are
increasingly recognised in PD (Baik et al. 2014; Hacker et al.
2012; Helmich et al. 2010; H. Yu et al. 2007) with cumulating
evidence for dysfunction of the entire intrinsic distribution of
the sensorimotor network (see review (Tahmasian et al.
2015)). Finally, further andmore neuroimaging studies in peo-
ple at high risk of developing PD, such as carriers of mutated
genes, may be able to provide more consistent insight into the
putative neural compensatorymechanisms underlying the mo-
tor preservation during the pre-symptomatic stage of PD.
Conclusions
Our CBMA reports the consistent activation pattern of known
cortical and subcortical motor networks in normal volunteers
and people with clinical Parkinson’s. We demonstrate striatal
and SMA hypoactivation as the core abnormality in
Parkinson’s off medication during motor tasks, which appears
to be reversed by restorative dopaminergic effect. Previous in-
consistent reports can be explained by a complex role of SMA/
pre-SMA activation changes in task- and medication-specific
variation in intention. Importantly, our meta-analysis reveals an
activity reduction in SMA during STN deep brain stimulation,
which might also underpin L-dopa related overcompensation.
We recommend more attention to be drawn to the neuronal
network alterations by combining resting and active state in
PD. Also, further high quality neuroimaging motor studies
should focus on the neural compensatory mechanisms underly-
ing the motor preservation in people at high risk of developing
PD or in the premotor stage.
Authors’ roles Y.X., C.T., D.P.A. designed research; Y.X., M.W., S.T.S.
executed the literature search; Y.X., and C.T. analysed data; Y.X., D.P.A.
wrote the paper, all authors edited the final draft.
Funding sources for study Y.X. and S.T.S were funded by Parkinson’s
UK (Grant reference: J-1204).
Compliance with ethical standards
Conflict of interest None.
Ethical approval All procedures performed in studies involving human
participants were in accordance with the ethical standards of the institu-
tional and/or national research committee and with the 1964 Helsinki
declaration and its later amendments or comparable ethical standards.
Informed consent Informed consent was obtained from all individual
participants included in the study.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Brain Imaging and Behavior
References
Agosta, F., Caso, F., Stankovic, I., Inuggi, A., Petrovic, I., Svetel, M.,
Kostic, V. S., & Filippi, M. (2014). Cortico-striatal-thalamic net-
work functional connectivity in hemiparkinsonism. Neurobiology
of Aging, 35(11), 2592–2602. https://doi.org/10.1016/j.
neurobiolaging.2014.05.032.
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel orga-
nization of functionally segregated circuits linking basal ganglia and
cortex. Annual Review of Neuroscience, 9, 357–381. https://doi.org/
10.1146/annurev.ne.09.030186.002041.
Anderson, D., Beecher, G., & Ba, F. (2017). Deep brain stimulation in
Parkinson’s disease: New and emerging targets for refractory motor
and nonmotor symptoms. Parkinson’s Disease., 2017, 1–13. https://
doi.org/10.1155/2017/5124328.
Asanuma, K., Tang, C., Ma, Y., Dhawan, V., Mattis, P., Edwards, C.,
Kaplitt, M. G., Feigin, A., & Eidelberg, D. (2006). Network modu-
lation in the treatment of Parkinson's disease. Brain, 129(Pt 10),
2667–2678. https://doi.org/10.1093/brain/awl162.
Baik, K., Cha, J., Ham, J. H., Baek, G. M., Sunwoo, M. K., Hong, J. Y.,
Shin, N. Y., Kim, J. S., Lee, J. M., Lee, S. K., Sohn, Y. H., & Lee, P.
H. (2014). Dopaminergic modulation of resting-state functional con-
nectivity in De novo patients with Parkinson's disease.HumanBrain
Mapping, 35(11), 5431–5441.
Benazzouz, A., Gao, D., Ni, Z., & Benabid, A. L. (2000). High frequency
stimulation of the STN influences the activity of dopamine neurons
in the rat. Neuroreport, 11, 1593–1596.
Benninger, D. H., & Hallett, M. (2015). Non-invasive brain stimulation
for Parkinson's disease: Current concepts and outlook 2015.
NeuroRehabilitation, 37(1), 11–24. https://doi.org/10.3233/nre-
151237.
Berding, G., Odin, P., Brooks, D. J., Nikkhah, G., Matthies, C., Peschel,
T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R.,
Samii, M., & Knapp, W. H. (2001). Resting regional cerebral glu-
cose metabolism in advanced Parkinson's disease studied in the off
and on conditions with [(18)F]FDG-PET. Movement Disorders,
16(6), 1014–1022.
Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994). The
primate subthalamic nucleus. II. Neuronal activity in the MPTP mod-
el of parkinsonism. Journal of Neurophysiology, 72(2), 507–520.
Bezard, E., Gross, C. E., & Brotchie, J. M. (2003). Presymptomatic com-
pensation in Parkinson's disease is not dopamine-mediated. Trends
in Neurosciences, 26(4), 215–221. https://doi.org/10.1016/S0166-
2236(03)00038-9.
Breakefield, X. O., Blood, A. J., Li, Y., Hallett, M., Hanson, P. I., &
Standaert, D. G. (2008). The pathophysiological basis of dystonias.
Nature Reviews. Neuroscience, 9(3), 222–234. https://doi.org/10.
1038/nrn2337.
Brotchie, J., & Fitzer-Attas, C. (2009). Mechanisms compensating for
dopamine loss in early Parkinson disease. Neurology, 72, S32–S38.
Bruck, A., Aalto, S., Nurmi, E., Vahlberg, T., Bergman, J., & Rinne, J. O.
(2006). Striatal subregional 6-[F-18]fluoro-L-dopa uptake in early
Parkinson's disease: A two-year follow-up study. Movement
Disorders, 21(7), 958–963.
Buhmann, C., Glauche, V., Sturenburg, H. J., Oechsner, M., Weiller, C.,
& Buchel, C. (2003). Pharmacologically modulated fMRI–cortical
responsiveness to levodopa in drug-naive hemiparkinsonian pa-
tients. Brain, 126(Pt 2), 451–461.
Buhmann, C., Binkofski, F., Klein, C., Buchel, C., van Eimeren, T.,
Erdmann, C., . . . Siebner, H. R. (2005). Motor reorganization in
asymptomatic carriers of a single mutant Parkin allele: A human
model for presymptomatic parkinsonism. Brain, 128(Pt 10), 2281–
2290. https://doi.org/10.1093/brain/awh572.
Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Di Filippo, M.
(2014). Direct and indirect pathways of basal ganglia: A critical
reappraisal. Nature Neuroscience, 17(8), 1022–1030. https://doi.
org/10.1038/nn.3743.
Cerasa, A., Pugliese, P., Messina, D., Morelli, M., Gioia, M. C., Salsone,
M., et al. (2012). Prefrontal alterations in Parkinson's disease with
levodopa-induced dyskinesia during fMRI motor task. Movement
Disorders, 27(3), 364–371. https://doi.org/10.1002/mds.24017.
Corbetta, M., Patel, G., & Shulman, G. L. (2008). The reorienting system
of the human brain: From environment to theory of mind. Neuron,
58(3), 306–324. https://doi.org/10.1016/j.neuron.2008.04.017.
de Lau, L. M., & Breteler, M. M. (2006). Epidemiology of Parkinson's
disease. Lancet Neurology, 5(6), 525–535. https://doi.org/10.1016/
s1474-4422(06)70471-9.
Deiber, M. P., Honda, M., Ibanez, V., Sadato, N., & Hallett, M. (1999).
Mesial motor areas in self-initiated versus externally triggered
movements examined with fMRI: Effect of movement type and rate.
Journal of Neurophysiology, 81(6), 3065–3077.
Delong, M. R. (1990). Primate models of movement-disorders of basal
ganglia origin. Trends in Neurosciences, 13(7), 281–285.
Dominey, P., Decety, J., Broussolle, E., Chazot, G., & Jeannerod, M.
(1995). Motor imagery of a lateralized sequential task is asymmet-
rically slowed in hemi-Parkinsons patients. Neuropsychologia,
33(6), 727–741. https://doi.org/10.1016/0028-3932(95)00008-Q.
Eidelberg, D. (2009). Metabolic brain networks in neurodegenerative disor-
ders: A functional imaging approach. Trends in Neurosciences, 32(10),
548–557. https://doi.org/10.1016/j.tins.2009.06.003.
Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S.,
Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski,
S., & Fahn, S. (1994). The metabolic topography of parkinsonism.
Journal of Cerebral Blood Flow and Metabolism, 14(5), 783–801.
Esposito, F., Tessitore, A., Giordano, A., De Micco, R., Paccone, A.,
Conforti, R., . . . Tedeschi, G. (2013). Rhythm-specific modulation
of the sensorimotor network in drug-naive patients with Parkinson's
disease by levodopa. Brain, 136, 710–725. https://doi.org/10.1093/
brain/awt007.
Fahn, S., Shoulson, I., Kieburtz, K., Rudolph, A., Lang, A., Olanow, C.
W., . . . Grp, P. S. (2004). Levodopa and the progression of
Parkinson's disease. New England Journal of Medicine, 351(24),
2498–2508.
Fearnley, J. M., & Lees, A. J. (1991). Ageing and Parkinson's disease:
Substantia nigra regional selectivity. Brain, 114(Pt 5), 2283–2301.
Goldberg, J. A., Boraud, T., Maraton, S., Haber, S. N., Vaadia, E., &
Bergman, H. (2002). Enhanced synchrony among primary motor
cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
primate model of Parkinson's disease. Journal of Neuroscience,
22(11), 4639–4653 20026424.
Hacker, C. D., Perlmutter, J. S., Criswell, S. R., Ances, B. M., & Snyder,
A. Z. (2012). Resting state functional connectivity of the striatum in
Parkinson's disease. Brain, 135, 3699–3711. https://doi.org/10.
1093/brain/aws281.
Hammond, C., Bergman, H., & Brown, P. (2007). Pathological synchro-
nization in Parkinson's disease: Networks, models and treatments.
Trends in Neurosciences, 30(7), 357–364. https://doi.org/10.1016/j.
tins.2007.05.004.
Haslinger, B., Erhard, P., Kampfe, N., Boecker, H., Rummeny, E.,
Schwaiger, M., . . . Ceballos-Baumann, A. O. (2001). Event-
related functional magnetic resonance imaging in Parkinson's dis-
ease before and after levodopa. Brain, 124, 558–570. https://doi.org/
10.1093/brain/124.3.558.
Helmich, R. C., Derikx, L. C., Bakker, M., Scheeringa, R., Bloem, B. R.,
& Toni, I. (2010). Spatial remapping of Cortico-striatal connectivity
in Parkinson's disease. Cerebral Cortex, 20(5), 1175–1186. https://
doi.org/10.1093/cercor/bhp178.
Hershey, T., Black, K., Carl, J., McGee-Minnich, L., Snyder, A., &
Perlmutter, J. (2003). Long term treatment and disease severity
change brain responses to levodopa in Parkinson's disease. Journal
Brain Imaging and Behavior
of Neurology, Neurosurgery, and Psychiatry, 74(7), 844–851.
https://doi.org/10.1136/jnnp.74.7.844.
Herz, D. M., Eickhoff, S. B., Lokkegaard, A., & Siebner, H. R. (2014a).
Functional neuroimaging of motor control in Parkinson's disease: A
meta-analysis. Human Brain Mapping, 35(7), 3227–3237. https://
doi.org/10.1002/hbm.22397.
Herz, D. M., Haagensen, B. N., Christensen, M. S., Madsen, K. H.,
Rowe, J. B., Lokkegaard, A., & Siebner, H. R. (2014b). The acute
brain response to levodopa heralds Dyskinesias in Parkinson dis-
ease. Annals of Neurology, 75(6), 829–836. https://doi.org/10.
1002/ana.24138.
Hilker, R., Voges, J., Ghaemi, M., Lehrke, R., Rudolf, J., Koulousakis,
A., Herholz, K., Wienhard, K., Sturm, V., & Heiss, W. D. (2003).
Deep brain stimulation of the subthalamic nucleus does not increase
the striatal dopamine concentration in parkinsonian humans.
Movement Disorders, 18, 41–48.
Hirano, S., Asanuma, K., Ma, Y., Tang, C., Feigin, A., Dhawan, V.,
Carbon, M., & Eidelberg, D. (2008). Dissociation of metabolic
and neurovascular responses to levodopa in the treatment of
Parkinson’s disease. The Journal of neuroscience : the official jour-
nal of the Society for Neuroscience, 28(16), 4201–4209. https://doi.
org/10.1523/JNEUROSCI.0582-08.2008.
Holloway, R., Shoulson, I., Kieburtz, K., McDermott, M., Tariot, P., Kamp,
C., . . . Grp, P. S. (2000). Pramipexole vs levodopa as initial treatment
for Parkinson disease - a randomized controlled trial. Jama-Journal of
the American Medical Association, 284(15), 1931–1938.
Houk, J. C., & Wise, S. P. (1995). Distributed modular architectures
linking basal ganglia, cerebellum, and cerebral cortex: Their role
in planning and controlling action. Cerebral Cortex, 5(2), 95–110.
Huang, C. R., Tang, C. K., Feigin, A., Lesser, M., Ma, Y. L., Pourfar, M., .
. . Eidelberg, D. (2007). Changes in network activity with the pro-
gression of Parkinson's disease. Brain, 130, 1834–1846.
Jahanshahi, M., Jenkins, I. H., Brown, R. G., Marsden, C. D.,
Passingham, R. E., & Brooks, D. J. (1995). Self-initiated versus
externally triggered movements. I. An investigation using measure-
ment of regional cerebral blood flow with PET and movement-
related potentials in normal and Parkinson's disease subjects.
Brain, 118(Pt 4), 913–933.
Jahanshahi, M., Obeso, I., Rothwell, J. C., & Obeso, J. A. (2015). A
fronto-striato-subthalamic-pallidal network for goal-directed and ha-
bitual inhibition. Nature Reviews. Neuroscience, 16(12), 719–732.
https://doi.org/10.1038/nrn4038.
Japee, S., Holiday, K., Satyshur, M. D., Mukai, I., & Ungerleider, L. G.
(2015). A role of right middle frontal gyrus in reorienting of atten-
tion: A case study. Frontiers in Systems Neuroscience, 9, 23. https://
doi.org/10.3389/fnsys.2015.00023.
Jenkins, I. H., Fernandez,W., Playford, E. D., Lees, A. J., Frackowiak, R.
S., Passingham, R. E., & Brooks, D. J. (1992). Impaired activation
of the supplementary motor area in Parkinson's disease is reversed
when akinesia is treated with apomorphine. Annals of Neurology,
32(6), 749–757. https://doi.org/10.1002/ana.410320608.
Kalmar, Z., Kovacs, N., Perlaki, G., Nagy, F., Aschermann, Z., Kerekes,
Z., Kaszas, B., Balas, I., Orsi, G., Komoly, S., Schwarcz, A., &
Janszky, J. (2011). Reorganization of motor system in Parkinson's
disease. European Neurology, 66(4), 220–226. https://doi.org/10.
1159/000330658.
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E.,
Pahwa, R., Lang, A. E., & Deuschl, G. (2006). Subthalamic nucleus
deep brain stimulation: Summary and meta-analysis of outcomes.
Movement Disorders, 21(Suppl 14), S290–S304. https://doi.org/10.
1002/mds.20962.
Kobari, M., Fukuuchi, Y., Shinohara, T., Obara, K., &Nogawa, S. (1995).
Levodopa-induced local cerebral blood flow changes in Parkinson's
disease and related disorders. Journal of the Neurological Sciences,
128(2), 212–218.
Kojovic, M., Parees, I., Sadnicka, A., Kassavetis, P., Rubio-Agusti, I.,
Saifee, T. A., . . . Bhatia, K. P. (2012). The brighter side of music
in dystonia. Archives of Neurology, 69(7), 917–919. https://doi.org/
10.1001/archneurol.2012.33.
Kravitz, A. V., Freeze, B. S., Parker, P. R., Kay, K., Thwin, M.
T., Deisseroth, K., & Kreitzer, A. C. (2010). Regulation of
parkinsonian motor behaviours by optogenetic control of bas-
al ganglia circuitry. Nature, 466(7306), 622–626. https://doi.
org/10.1038/nature09159.
Kwak, Y., Peltier, S., Bohnen, N. I., Muller, M. L., Dayalu, P., & Seidler,
R. D. (2010). Altered resting state cortico-striatal connectivity in
mild to moderate stage Parkinson's disease. Frontiers in Systems
Neuroscience, 4, 143. https://doi.org/10.3389/fnsys.2010.00143.
Liepelt, I., Reimold, M., Maetzler, W., Godau, J., Reischl, G., Gaenslen,
A., Herbst, H., & Berg, D. (2009). Cortical hypometabolism
assessed by a metabolic ratio in Parkinson's disease primarily re-
flects cognitive deterioration-[18F]FDG-PET. Movement
Disorders, 24(10), 1504–1511. https://doi.org/10.1002/mds.22662.
Lin, W. C., Chen, P. C., Huang, Y. C., Tsai, N. W., Chen, H. L., Wang, H.
C., Lin, T. K., Chou, K. H., Chen, M. H., Chen, Y. W., & Lu, C. H.
(2016). Dopaminergic therapy modulates cortical perfusion in
Parkinson disease with andwithout dementia according to arterial spin
labeled perfusion magnetic resonance imaging.Medicine (Baltimore),
95(5), e2206. https://doi.org/10.1097/md.0000000000002206.
Ma, Y. L., Tang, C. K., Spetsieris, P. G., Dhawan, V., & Eidelberg, D.
(2007). Abnormal metabolic network activity in Parkinson's disease:
Test-retest reproducibility. Journal of Cerebral Blood Flow and
Metabolism, 27(3), 597–605.
Mallol, R., Barros-Loscertales, A., Lopez,M., Belloch, V., Parcet, M. A., &
Avila, C. (2007). Compensatory cortical mechanisms in Parkinson's
disease evidenced with fMRI during the performance of pre-learned
sequential movements. Brain Research, 1147, 265–271. https://doi.
org/10.1016/j.brainres.2007.02.046.
Melamed, E., Globus, M., & Mildworf, B. (1986). Regional cerebral
blood flow in patients with Parkinson's disease under chronic levo-
dopa therapy: Measurements during "on" and "off" response fluctu-
ations. Journal of Neurology, Neurosurgery, and Psychiatry, 49(11),
1301–1304.
MuthuramanM, Deuschl G, Koirala N, Riedel C, Volkmann J, Groppa S.
Effects of DBS in parkinsonian patients depend on the structural
integrity of frontal cortex. Sci Rep. 2017;7:43571. Published 2017
Mar 6. https://doi.org/10.1038/srep43571
Nakajima, T., Nimura, T., Yamaguchi, K., Ando, T., Itoh, M., Yoshimoto,
T., & Shirane, R. (2003). The impact of stereotactic pallidal surgery
on the dopamine D2 receptor in Parkinson disease: A positron emis-
sion tomography study. Journal of Neurosurgery, 98, 57–63.
Nambu, A., Tokuno, H., & Takada, M. (2002). Functional significance of
the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neuroscience
Research, 43(2), 111–117.
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J.,
McKenzie, J., McCormick, S., Ruth, T. J., Sossi, V., de la Fuente-
Fernandez, R., & Stoessl, A. J. (2011). Longitudinal evolution of com-
pensatory changes in striatal dopamine processing in Parkinson's dis-
ease. Brain, 134, 3290–3298. https://doi.org/10.1093/brain/awr233.
Nurmi, E., Ruottinen, H. M., Bergman, J., Haaparanta, M., Solin, O.,
Sonninen, P., & Rinne, J. O. (2001). Rate of progression in
Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study.
Movement Disorders, 16(4), 608–615.
Perestelo-Perez, L., Rivero-Santana, A., Perez-Ramos, J., Serrano-Perez,
P., Panetta, J., & Hilarion, P. (2014). Deep brain stimulation in
Parkinson's disease: Meta-analysis of randomized controlled trials.
Journal of Neurology, 261(11), 2051–2060. https://doi.org/10.1007/
s00415-014-7254-6.
Playford, E. D., Jenkins, I. H., Passingham, R. E., Nutt, J., Frackowiak, R.
S., & Brooks, D. J. (1992). Impaired mesial frontal and putamen
activation in Parkinson's disease: A positron emission tomography
Brain Imaging and Behavior
study. Annals of Neurology, 32(2), 151–161. https://doi.org/10.
1002/ana.410320206.
Pleger, B., Foerster, A. F., Ragert, P., Dinse, H. R., Schwenkreis, P.,
Malin, J. P., Nicolas, V., & Tegenthoff, M. (2003). Functional imag-
ing of perceptual learning in human primary and secondary somato-
sensory cortex. Neuron, 40(3), 643–653.
Poewe,W. H., Lees, A. J., & Stern, G.M. (1988). Dystonia in Parkinson's
disease: Clinical and pharmacological features. Annals of
Neurology, 23(1), 73–78. https://doi.org/10.1002/ana.410230112.
Poisson, A., Ballanger, B., Metereau, E., Redoute, J., Ibarolla, D., Comte,
J. C., . . . Thobois, S. (2013). A functional magnetic resonance
imaging study of pathophysiological changes responsible for mirror
movements in Parkinson's disease. PLoS One, 8(6), e66910. https://
doi.org/10.1371/journal.pone.0066910.
Politis, M. (2014). Neuroimaging in Parkinson disease: From research set-
ting to clinical practice. Nature Reviews Neurology, 10(12), 708–722.
Ponce, F. A., & Lozano, A. M. (2010). Deep brain stimulation state of the
art and novel stimulation targets. Progress in Brain Research, 184,
311–324. https://doi.org/10.1016/S0079-6123(10)84016-6.
PS, G. (2002). A controlled trial of rasagiline in early Parkinson disease:
The TEMPO study. Archives of Neurology, 59(12), 1937–1943.
Purves, D. (2012). Neuroscience (5th ed.). Sunderland: Sinauer Associates.
Rascol, O., Sabatini, U., Chollet, F., Fabre, N., Senard, J. M., Montastruc,
J. L., Celsis, P., Marc-Vergnes, J. P., & Rascol, A. (1994). Normal
activation of the supplementary motor area in patients with
Parkinsons-disease undergoing Long-term treatment with levodopa.
Journal of Neurology Neurosurgery and Psychiatry, 57(5), 567–
571. https://doi.org/10.1136/jnnp.57.5.567.
Rivlin-Etzion, M., Ritov, Y., Heimer, G., Bergman, H., & Bar-Gad, I.
(2006). Local shuffling of spike trains boosts the accuracy of spike
train spectral analysis. Journal of Neurophysiology, 95(5), 3245–
3256. https://doi.org/10.1152/jn.00055.2005.
Samuel, M., Ceballos-Baumann, A. O., Blin, J., Uema, T., Boecker, H.,
Passingham, R. E., & Brooks, D. J. (1997). Evidence for lateral
premotor and parietal overactivity in Parkinson's disease during se-
quential and bimanual movements. A PET study. Brain, 120(Pt 6),
963–976.
Shirota, Y., Hamada, M., & Ugawa, Y. (2016). Clinical applications of
rTMS in Parkinson’s disease. In T. Platz (Ed.), Therapeutic rTMS in
neurology: Principles, evidence, and practice recommendations
(pp. 129–145). Cham: Springer International Publishing.
Strafella, A. P., Paus, T., Fraraccio, M., & Dagher, A. (2003a). Striatal
dopamine release induced by repetitive transcranial magnetic stim-
ulation of the human motor cortex. Brain, 126(Pt 12), 2609–2615.
https://doi.org/10.1093/brain/awg268.
Strafella, A. P., Sadikot, A. F., & Dagher, A. (2003b). Subthalamic deep
brain stimulation does not induce striatal dopamine release in
Parkinson’s disease. Neuroreport, 14, 1287–1289.
Strafella, A. P., Ko, J. H., & Monchi, O. (2006). Therapeutic application
of transcranial magnetic stimulation in Parkinson's disease: The con-
tribution of expectation.Neuroimage, 31(4), 1666–1672. https://doi.
org/10.1016/j.neuroimage.2006.02.005.
Tahmasian, M., Bettray, L. M., van Eimeren, T., Drzezga, A.,
Timmermann, L., Eickhoff, C. R., Eickhoff, S. B., & Eggers, C.
(2015). A systematic review on the applications of resting-state
fMRI in Parkinson's disease: Does dopamine replacement therapy
play a role? Cortex, 73, 80–105.
Tanasescu, R., Cottam, W. J., Condon, L., Tench, C. R., & Auer, D. P.
(2016). Functional reorganisation in chronic pain and neural correlates
of pain sensitisation: A coordinate based meta-analysis of 266 cuta-
neous pain fMRI studies. Neuroscience and Biobehavioral Reviews,
68, 120–133. https://doi.org/10.1016/j.neubiorev.2016.04.001.
Taniwaki, T., Yoshiura, T., Ogata, K., Togao, O., Yamashita, K., Kida, H.,
Miura, S., Kira, J. I., & Tobimatsu, S. (2013). Disrupted connectivity
of motor loops in Parkinson's disease during self-initiated but not
externally-triggered movements. Brain Research, 1512, 45–59.
https://doi.org/10.1016/j.brainres.2013.03.027.
Tench, C. R., Tanasescu, R., Auer, D. P., & Constantinescu, C. S. (2013).
Coordinate based meta-analysis of functional neuroimaging data;
false discovery control and diagnostics. PLoS One, 8(7), e70143.
https://doi.org/10.1371/journal.pone.0070143.
Tench, C. R., Tanasescu, R., Auer, D. P., Cottam, W. J., &
Constantinescu, C. S. (2014). Coordinate based meta-analysis of
functional neuroimaging data using activation likelihood estimation;
full width half max and group comparisons. PLoS One, 9(9),
e106735. https://doi.org/10.1371/journal.pone.0106735.
Thanvi, B., Lo, N., & Robinson, T. (2007). Levodopa-induced dyskinesia
in Parkinson's disease: Clinical features, pathogenesis, prevention
and treatment. Postgraduate Medical Journal, 83(980), 384–388.
https://doi.org/10.1136/pgmj.2006.054759.
Tinkhauser, G., Pogosyan, A., Tan, H., Herz, D. M., Kühn, A. A., &
Brown, P. (2017a). Beta burst dynamics in Parkinson's disease
OFF and ON dopaminergic medication. Brain, 140, 2968–2981.
https://doi.org/10.1093/brain/awx252.
Tinkhauser, G., Pogosyan, A., Little, S., Beudel,M., Herz, D.M., Tan, H.,
& Brown, P. (2017b). The modulatory effect of adaptive deep brain
stimulation on beta bursts in Parkinson's disease. Brain, 140, 1053–
1067. https://doi.org/10.1093/brain/awx010.
Tziortzi, A. C., Haber, S. N., Searle, G. E., Tsoumpas, C., Long, C. J.,
Shotbolt, P., Douaud, G., Jbabdi, S., Behrens, T. E. J., Rabiner, E.
A., Jenkinson, M., & Gunn, R. N. (2014). Connectivity-based func-
tional analysis of dopamine release in the striatum using diffusion-
weighted MRI and positron emission tomography. Cerebral Cortex,
24(5), 1165–1177. https://doi.org/10.1093/cercor/bhs397.
van Eimeren, T., & Siebner, H. R. (2006). An update on functional neu-
roimaging of parkinsonism and dystonia. Current Opinion in
Neurology, 19(4), 412–419. https://doi.org/10.1097/01.wco.
0000236623.68625.54.
van Nuenen, B. F., van Eimeren, T., van der Vegt, J. P., Buhmann, C.,
Klein, C., Bloem, B. R., & Siebner, H. R. (2009a). Mapping pre-
clinical compensation in Parkinson's disease: An imaging genomics
approach. Movement Disorders, 24(Suppl 2), S703–S710. https://
doi.org/10.1002/mds.22635.
van Nuenen, B. F., Weiss, M. M., Bloem, B. R., Reetz, K., van Eimeren,
T., Lohmann, K., . . . Siebner, H. R. (2009b). Heterozygous carriers
of a Parkin or PINK1 mutation share a common functional
endophenotype. Neurology, 72(12), 1041–1047. https://doi.org/10.
1212/01.wnl.0000338699.56379.11.
Vitek, J. L. (2002). Pathophysiology of dystonia: A neuronal model.
Movement Disorders, 17(Suppl 3), S49–S62.
Wichmann, T., DeLong, M. R., Guridi, J., & Obeso, J. A. (2011).
Milestones in research on the pathophysiology of Parkinson's dis-
ease. Movement Disorders, 26(6), 1032–1041. https://doi.org/10.
1002/mds.23695.
Wu, T., Wang, L., Chen, Y., Zhao, C., Li, K. C., & Chan, P. (2009).
Changes of functional connectivity of the motor network in the
resting state in Parkinson's disease. Neuroscience Letters, 460(1),
6–10. https://doi.org/10.1016/j.neulet.2009.05.046.
Yu, H., Sternad, D., Corcos, D. M., & Vaillancourt, D. E. (2007). Role of
hyperactive cerebellum and motor cortex in Parkinson's disease.
Neuroimage, 35(1), 222–233. https://doi.org/10.1016/j.neuroimage.
2006.11.047.
Yu, R., Liu, B., Wang, L., Chen, J., & Liu, X. (2013). Enhanced func-
tional connectivity between putamen and supplementary motor area
in Parkinson’s disease patients. PLoS One, 8(3), e59717. https://doi.
org/10.1371/journal.pone.0059717.
Zigmond, M. J., Acheson, A. L., Stachowiak, M. K., & Strickerm, E. M.
(1984). Neurochemical compensation after nigrostriatal bundle in-
jury in an animal-model of preclinical parkinsonism. Archives of
Neurology, 41(8), 856–861.
Brain Imaging and Behavior
